Treatment for the condition has come a long way since Pilon began in skincare four decades ago. “Today, we have so much more opportunity in treating acne in a healthier way,” she said. “We can basically change people’s lives.” And while the acne product space is definitely crowded, she noted there’s always room for acne product development, especially given the breadth of the population that has acne.
Pilon was joined on the webinar by Joyce B. Farah, dermatologist and founder of Farah Dermatology & Cosmetics, and Sara Turchetta, VP of Europelab. The trio delved into the physiology of acne, the differences between cosmetic-grade and medical-grade products, and what brands should include in an acne product line. Below, we recap key points from their conversation.
By TAYLOR BRYANT – FEBRUARY 7, 2022
Welcome to this 33rd edition of ZOOM, a magazine dedicated to preclinical trials and clinical…
Precision and reliability are essential in dermatology and aesthetics. The Antera 3D CS by Miravex…
PhD Trials, one of the leading CROs for performing in vivo studies with cosmetic products…